Study of congenital muscle disease patients and their families
Part of Bones, joints & muscles, Brain & nervous system, Eyes & vision, Genetic & congenital, Mental health clinical trials.
This trial collects health information from patients with certain inherited (genetic) muscle diseases and from their families. It may help researchers better understand the disease and improve care by learning what symptoms and treatments patients experience over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a genetic (inherited) muscle disease in the study’s listed groups
- Your condition is one of the approved muscle disease types (not one of the excluded types)
- You and/or your family can share medical details by report (paper or online forms)
- You (and/or your caregiver) can answer questions about symptoms and care
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with LAMA2-related muscular dystrophy over time to better understand the condition. It may help with future treatments by learning more about how the disease progresses.
This study follows people with congenital myasthenic syndrome (CMS) caused by changes in certain genes (DOK7, MUSK, AGRN, or LRP4) over time. It does not test any new drug, but helps researchers understand how the condition changes and how to plan future treatments.
This study follows people with LAMA2-related muscular dystrophy (a genetic muscle-weakening condition) to learn how it changes over time and find better ways to measure it. By participating, you help researchers identify new disease markers that could improve future treatments.
This study looks at people and families with a rare muscle weakness condition that can be linked with Paget disease of the bone (and sometimes frontotemporal dementia). It aims to better describe how these conditions appear and relate, which can help future research and care.
This trial is for people who have signs that they may have a dystroglycanopathy—a group of muscle conditions. It helps study how ready participants are for care and possibly future treatments by using lab and genetic/pathology information to confirm the condition.
This study tracks changes in muscle strength and breathing over time in people with certain types of muscular dystrophy. It helps researchers develop better tests to measure how the disease progresses.
Hear when a new Merosin Deficient CMD (Full or Partial) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.